{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:09:50Z","timestamp":1764079790599,"version":"3.40.5"},"publisher-location":"Cham","reference-count":65,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030880705"},{"type":"electronic","value":"9783030880712"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-030-88071-2_17","type":"book-chapter","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T14:03:15Z","timestamp":1652882595000},"page":"415-439","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Overview of Adverse Outcome Pathways and Current Applications on Nanomaterials"],"prefix":"10.1007","author":[{"given":"Dora","family":"Rolo","sequence":"first","affiliation":[]},{"given":"Ana","family":"Tavares","sequence":"additional","affiliation":[]},{"given":"N\u00e1dia","family":"Vital","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6060-0716","authenticated-orcid":false,"given":"Maria Jo\u00e3o","family":"Silva","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9744-7332","authenticated-orcid":false,"given":"Henriqueta","family":"Louro","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"issue":"3","key":"17_CR1","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/etc.34","volume":"29","author":"GT Ankley","year":"2010","unstructured":"Ankley GT, Bennett RS, Erickson RJ, Hoff DJ et al (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29(3):730\u2013741. https:\/\/doi.org\/10.1002\/etc.34","journal-title":"Environ Toxicol Chem"},{"issue":"4","key":"17_CR2","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1021\/acsnano.9b06860","volume":"14","author":"H Barosova","year":"2020","unstructured":"Barosova H, Maione AG, Septiadi D, Sharma M et al (2020) Use of EpiAlveolar lung model to predict fibrotic potential of multiwalled carbon nanotubes. ACS Nano 14(4):3941\u20133956. https:\/\/doi.org\/10.1021\/acsnano.9b06860","journal-title":"ACS Nano"},{"issue":"8","key":"17_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nano10081516","volume":"10","author":"A Bettencourt","year":"2020","unstructured":"Bettencourt A, Gon\u00e7alves LM, Gramacho AC, Vieira A et al (2020) Analysis of the characteristics and cytotoxicity of titanium dioxide nanomaterials following simulated in vitro digestion. Nano 10(8):1\u201318. https:\/\/doi.org\/10.3390\/nano10081516","journal-title":"Nano"},{"issue":"2","key":"17_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/cod.13669","volume":"84","author":"SF Bezerra","year":"2021","unstructured":"Bezerra SF, Santos Rodrigues B, Silva ACG, \u00c1vila RI et al (2021) Application of the adverse outcome pathway framework for investigating skin sensitization potential of nanomaterials using new approach methods. Contact Dermatitis 84(2):67\u201374. https:\/\/doi.org\/10.1111\/cod.13669","journal-title":"Contact Dermatitis"},{"issue":"1","key":"17_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-pharmtox-101419-100049","volume":"61","author":"HM Braakhuis","year":"2021","unstructured":"Braakhuis HM, Gosens I, Heringa MB, Oomen AG et al (2021) Mechanism of action of TiO 2\u00a0: recommendations to reduce uncertainties related to carcinogenic potential. Annu Rev Pharmacol Toxicol 61(1):203\u2013223. https:\/\/doi.org\/10.1146\/annurev-pharmtox-101419-100049","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"7","key":"17_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1080\/17435390.2020.1778809","volume":"14","author":"W Brand","year":"2020","unstructured":"Brand W, Peters RJB, Braakhuis HM, Ma\u015blankiewicz L et al (2020) Possible effects of titanium dioxide particles on human liver, intestinal tissue, spleen and kidney after oral exposure. Nanotoxicology 14(7):985\u20131007. https:\/\/doi.org\/10.1080\/17435390.2020.1778809","journal-title":"Nanotoxicology"},{"issue":"2","key":"17_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/toxsci\/kfx097","volume":"158","author":"EK Brockmeier","year":"2017","unstructured":"Brockmeier EK, Hodges G, Hutchinson TH, Butler E et al (2017) The role of omics in the application of adverse outcome pathways for chemical risk assessment. Toxicol Sci 158(2):252\u2013262. https:\/\/doi.org\/10.1093\/toxsci\/kfx097","journal-title":"Toxicol Sci"},{"key":"17_CR8","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.scitotenv.2018.02.015","volume":"628\u2013629","author":"A Carusi","year":"2018","unstructured":"Carusi A, Davies MR, De Grandis G, Escher BI et al (2018) Harvesting the promise of AOPs: an assessment and recommendations. Sci Total Environ 628\u2013629:1542\u20131556. https:\/\/doi.org\/10.1016\/j.scitotenv.2018.02.015","journal-title":"Sci Total Environ"},{"issue":"73","key":"17_CR9","doi-asserted-by":"publisher","first-page":"68606","DOI":"10.1039\/c6ra06006d","volume":"6","author":"N Chatterjee","year":"2016","unstructured":"Chatterjee N, Yang J, Atluri R, Lee W et al (2016) Amorphous silica nanoparticle-induced perturbation of cholesterol homeostasis as a function of surface area highlights safe-by-design implementation: an integrated multi-OMICS analysis. RSC Adv 6(73):68606\u201368614. https:\/\/doi.org\/10.1039\/c6ra06006d","journal-title":"RSC Adv"},{"issue":"4","key":"17_CR10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/ieam.4153","volume":"15","author":"K Coady","year":"2019","unstructured":"Coady K, Browne P, Embry M, Hill T et al (2019) When are adverse outcome pathways and associated assays \u201cfit for purpose\u201d for regulatory decision-making and management of chemicals? Integr Environ Assess Manag 15(4):633\u2013647. https:\/\/doi.org\/10.1002\/ieam.4153","journal-title":"Integr Environ Assess Manag"},{"issue":"6","key":"17_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nano10061229","volume":"10","author":"JD Ede","year":"2020","unstructured":"Ede JD, Lobaskin V, Vogel U, Lynch I et al (2020) Translating scientific advances in the AOP framework to decision making for nanomaterials. Nanomaterials 10(6):1\u201322. https:\/\/doi.org\/10.3390\/nano10061229","journal-title":"Nanomaterials"},{"issue":"1","key":"17_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1124\/jpet.115.228239","volume":"356","author":"SW Edwards","year":"2015","unstructured":"Edwards SW, Tan Y-M, Villeneuve DL, Meek ME et al (2015) Adverse outcome pathways--organizing toxicological information to improve decision making. J Pharmacol Exp Ther 356(1):170\u2013181. https:\/\/doi.org\/10.1124\/jpet.115.228239","journal-title":"J Pharmacol Exp Ther"},{"key":"17_CR13","doi-asserted-by":"publisher","unstructured":"EFSA Scientific Committee, Hardy A, Benford D, Thorhallur Halldorsson MJJ, Knutsen HK, More S, Naegeli H, Hubert Noteborn CO, Ricci A, Rychen G, Schlatter JR, Vittorio Silano RS et al (2018) Guidance on risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain: part 1, human and animal health. EFSA J 16(7). https:\/\/doi.org\/10.2903\/j.efsa.2018.5327","DOI":"10.2903\/j.efsa.2018.5327"},{"key":"17_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.comtox.2016.07.001","volume":"1","author":"K Gerloff","year":"2017","unstructured":"Gerloff K, Landesmann B, Worth A, Munn S et al (2017) The adverse outcome pathway approach in nanotoxicology. Computation Toxicol 1:3\u201311. https:\/\/doi.org\/10.1016\/j.comtox.2016.07.001","journal-title":"Computation Toxicol"},{"issue":"4","key":"17_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/17435390.2018.1446559","volume":"12","author":"SIL Gomes","year":"2018","unstructured":"Gomes SIL, Roca CP, Pegoraro N, Trindade T et al (2018) High-throughput tool to discriminate effects of NMs (Cu-NPs, Cu-nanowires, CuNO 3, and Cu salt aged): transcriptomics in Enchytraeus crypticus. Nanotoxicology 12(4):325\u2013340. https:\/\/doi.org\/10.1080\/17435390.2018.1446559","journal-title":"Nanotoxicology"},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.envpol.2018.10.123","volume":"245","author":"SIL Gomes","year":"2019","unstructured":"Gomes SIL, Roca CP, Scott-Fordsmand JJ, Amorim MJB (2019) High-throughput transcriptomics: insights into the pathways involved in (nano) nickel toxicity in a key invertebrate test species. Environ Pollut 245:131\u2013140. https:\/\/doi.org\/10.1016\/j.envpol.2018.10.123","journal-title":"Environ Pollut"},{"issue":"1","key":"17_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1465","volume":"10","author":"S Halappanavar","year":"2018","unstructured":"Halappanavar S, Vogel U, Wallin H, Yauk CL (2018) Promise and peril in nanomedicine: the challenges and needs for integrated systems biology approaches to define health risk. Wiley Interdiscip Rev Nanomed Nanobiotechnol 10(1):e1465. https:\/\/doi.org\/10.1002\/wnan.1465","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"July","key":"17_CR18","doi-asserted-by":"publisher","first-page":"100178","DOI":"10.1016\/j.impact.2019.100178","volume":"15","author":"S Halappanavar","year":"2019","unstructured":"Halappanavar S, Ede JD, Shatkin JA, Krug HF (2019) A systematic process for identifying key events for advancing the development of nanomaterial relevant adverse outcome pathways. NanoImpact 15(July):100178. https:\/\/doi.org\/10.1016\/j.impact.2019.100178","journal-title":"NanoImpact"},{"issue":"1","key":"17_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12989-020-00344-4","volume":"17","author":"S Halappanavar","year":"2020","unstructured":"Halappanavar S, van den Brule S, Nymark P, Gat\u00e9 L et al (2020a) Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale. Part Fibre Toxicol 17(1):16. https:\/\/doi.org\/10.1186\/s12989-020-00344-4","journal-title":"Part Fibre Toxicol"},{"key":"17_CR20","doi-asserted-by":"publisher","unstructured":"Halappanavar, S., Ede, J.D., Mahapatra, I., Krug, H.F., et al. (2020b) A methodology for developing key events to advance nanomaterial-relevant adverse outcome pathways to inform risk assessment. Nanotoxicology 0 (0), 1\u201324. doi:https:\/\/doi.org\/10.1080\/17435390.2020.1851419","DOI":"10.1080\/17435390.2020.1851419"},{"issue":"15","key":"17_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202007628","volume":"17","author":"S Halappanavar","year":"2021","unstructured":"Halappanavar S, Nymark P, Krug HF, Clift MJD, Rothen-Rutishauser B, Vogel U (2021) Non-animal strategies for toxicity assessment of nanoscale materials: role of adverse outcome pathways in the selection of endpoints. Small 17(15):e2007628. https:\/\/doi.org\/10.1002\/smll.202007628. Epub 2021 Feb 9","journal-title":"Small"},{"issue":"1","key":"17_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12989-016-0158-0","volume":"13","author":"F Huaux","year":"2015","unstructured":"Huaux F, d\u2019Ursel de Bousies V, Parent M-A, Orsi M et al (2015) Mesothelioma response to carbon nanotubes is associated with an early and selective accumulation of immunosuppressive monocytic cells. Part Fibre Toxicol 13(1):46. https:\/\/doi.org\/10.1186\/s12989-016-0158-0","journal-title":"Part Fibre Toxicol"},{"issue":"10","key":"17_CR23","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1080\/17435390.2018.1529835","volume":"12","author":"J Jeong","year":"2018","unstructured":"Jeong J, Song T, Chatterjee N, Choi I et al (2018) Developing adverse outcome pathways on silver nanoparticle-induced reproductive toxicity via oxidative stress in the nematode Caenorhabditis elegans using a Bayesian network model. Nanotoxicology 12(10):1182\u20131197. https:\/\/doi.org\/10.1080\/17435390.2018.1529835","journal-title":"Nanotoxicology"},{"issue":"3","key":"17_CR24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.15430\/jcp.2018.23.3.126","volume":"23","author":"DS Kang","year":"2018","unstructured":"Kang DS, Yang JH, Kim HS, Koo BK et al (2018) Application of the adverse outcome pathway framework to risk assessment for predicting carcinogenicity of chemicals. J Cancer Prevent 23(3):126\u2013133. https:\/\/doi.org\/10.15430\/jcp.2018.23.3.126","journal-title":"J Cancer Prevent"},{"issue":"April","key":"17_CR25","doi-asserted-by":"publisher","first-page":"105297","DOI":"10.1016\/j.aquatox.2019.105297","volume":"216","author":"B Khan","year":"2019","unstructured":"Khan B, Adeleye AS, Burgess RM, Russo SM et al (2019) Effects of graphene oxide nanomaterial exposures on the marine bivalve, Crassostrea virginica. Aquat Toxicol 216(April):105297. https:\/\/doi.org\/10.1016\/j.aquatox.2019.105297","journal-title":"Aquat Toxicol"},{"issue":"1","key":"17_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-17495-8","volume":"7","author":"H Kim","year":"2017","unstructured":"Kim H, Jeong J, Chatterjee N, Roca CP et al (2017) JAK\/STAT and TGF-\u00df activation as potential adverse outcome pathway of TiO2NPs phototoxicity in Caenorhabditis elegans. Sci Rep 7(1):1\u201312. https:\/\/doi.org\/10.1038\/s41598-017-17495-8","journal-title":"Sci Rep"},{"key":"17_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.reprotox.2015.04.003","volume":"56","author":"D Knapen","year":"2015","unstructured":"Knapen D, Vergauwen L, Villeneuve DL, Ankley GT (2015) The potential of AOP networks for reproductive and developmental toxicity assay development. Reprod Toxicol 56:52\u201355. https:\/\/doi.org\/10.1016\/j.reprotox.2015.04.003","journal-title":"Reprod Toxicol"},{"issue":"1","key":"17_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12989-016-0125-9","volume":"13","author":"S Labib","year":"2015","unstructured":"Labib S, Williams A, Yauk CL, Nikota JK et al (2015) Nano-risk science: application of toxicogenomics in an adverse outcome pathway framework for risk assessment of multi-walled carbon nanotubes. Part Fibre Toxicol 13(1):15. https:\/\/doi.org\/10.1186\/s12989-016-0125-9","journal-title":"Part Fibre Toxicol"},{"issue":"6","key":"17_CR29","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/etc.3805","volume":"36","author":"CA LaLone","year":"2017","unstructured":"LaLone CA, Ankley GT, Belanger SE, Embry MR et al (2017) Advancing the adverse outcome pathway framework \u2013 an international horizon scanning approach. Environ Toxicol Chem 36(6):1411\u20131421. https:\/\/doi.org\/10.1002\/etc.3805","journal-title":"Environ Toxicol Chem"},{"key":"17_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-72041-8_8","volume-title":"Advances in experimental medicine and biology","author":"H Louro","year":"2018","unstructured":"Louro H (2018) Relevance of physicochemical characterization of nanomaterials for understanding nano-cellular interactions. In: Advances in experimental medicine and biology. https:\/\/doi.org\/10.1007\/978-3-319-72041-8_8"},{"key":"17_CR31","doi-asserted-by":"publisher","unstructured":"Louro H, Pinh\u00e3o M, Santos J, Tavares A et al (2016) Evaluation of the cytotoxic and genotoxic effects of benchmark multi-walled carbon nanotubes in relation to their physicochemical properties. Toxicol Lett. https:\/\/doi.org\/10.1016\/j.toxlet.2016.09.016","DOI":"10.1016\/j.toxlet.2016.09.016"},{"key":"17_CR32","doi-asserted-by":"publisher","unstructured":"Louro H, Saruga A, Santos J, Pinh\u00e3o M et al (2019) Biological impact of metal nanomaterials in relation to their physicochemical characteristics. Toxicol In Vitro. https:\/\/doi.org\/10.1016\/J.TIV.2019.01.018","DOI":"10.1016\/J.TIV.2019.01.018"},{"issue":"42","key":"17_CR33","doi-asserted-by":"publisher","first-page":"18070","DOI":"10.1039\/C6NR06041B","volume":"8","author":"J Ma","year":"2016","unstructured":"Ma J, Li R, Qu G, Liu H et al (2016) Carbon nanotubes stimulate synovial inflammation by inducing systemic pro-inflammatory cytokines. Nanoscale 8(42):18070\u201318086. https:\/\/doi.org\/10.1039\/C6NR06041B","journal-title":"Nanoscale"},{"issue":"15","key":"17_CR34","doi-asserted-by":"publisher","first-page":"1603830","DOI":"10.1002\/smll.201603830","volume":"13","author":"J Ma","year":"2017","unstructured":"Ma J, Li R, Liu Y, Qu G et al (2017) Carbon nanotubes disrupt iron homeostasis and induce anemia of inflammation through inflammatory pathway as a secondary effect distant to their portal-of-entry. Small 13(15):1603830. https:\/\/doi.org\/10.1002\/smll.201603830","journal-title":"Small"},{"key":"17_CR35","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.chemosphere.2018.05.019","volume":"207","author":"Y-B Ma","year":"2018","unstructured":"Ma Y-B, Lu C-J, Junaid M, Jia P-P et al (2018) Potential adverse outcome pathway (AOP) of silver nanoparticles mediated reproductive toxicity in zebrafish. Chemosphere 207:320\u2013328. https:\/\/doi.org\/10.1016\/j.chemosphere.2018.05.019","journal-title":"Chemosphere"},{"issue":"1","key":"17_CR36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/17435390.2018.1513092","volume":"13","author":"A Mech","year":"2019","unstructured":"Mech A, Rasmussen K, Jantunen P, Aicher L et al (2019) Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation. Nanotoxicology 13(1):119\u2013141. https:\/\/doi.org\/10.1080\/17435390.2018.1513092","journal-title":"Nanotoxicology"},{"issue":"1","key":"17_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12989-017-0218-0","volume":"14","author":"J Nikota","year":"2017","unstructured":"Nikota J, Banville A, Goodwin LR, Wu D et al (2017) Stat-6 signaling pathway and not Interleukin-1 mediates multi-walled carbon nanotube-induced lung fibrosis in mice: insights from an adverse outcome pathway framework. Part Fibre Toxicol 14(1):37. https:\/\/doi.org\/10.1186\/s12989-017-0218-0","journal-title":"Part Fibre Toxicol"},{"issue":"Supplement_2","key":"17_CR38","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1513\/AnnalsATS.201706-478MG","volume":"15","author":"P Nymark","year":"2018","unstructured":"Nymark P, Kohonen P, Hongisto V, Grafstr\u00f6m RC (2018) Toxic and genomic influences of inhaled nanomaterials as a basis for predicting adverse outcome. Ann Am Thorac Soc 15(Supplement_2):S91\u2013S97. https:\/\/doi.org\/10.1513\/AnnalsATS.201706-478MG","journal-title":"Ann Am Thorac Soc"},{"key":"17_CR39","unstructured":"OCDE (2018). Environment directorate joint meeting of the chemicals committee and the working party on chemicals, pesticides and biotechnology (233), 1\u201362. Available from: https:\/\/one.oecd.org\/document\/ENV\/JM\/MONO(2016)12\/en\/pdf"},{"key":"17_CR40","unstructured":"OECD (2016a) Alternative testing strategies in risk assessment of manufactured nanomaterials: current state of knowledge and research needs to advance their use. OECD Environment, Health and Safety Publications Series on the Safety of Manufactured Nanomaterials No 80 JT03408320. (80), 36"},{"key":"17_CR41","unstructured":"OECD (2016b) OECD, \u2018Guidance document for the use of adverse outcome pathways in developing Integrated Approaches to Testing and Assessment (IATA),\u2019 OCED Series on Testing & amp; Assessment No. 260 JT03407308, OECD Publishing, Paris, 2016. OECD Guidelines for the Testing of Chemicals. Available from: http:\/\/www.oecd.org\/officialdocuments\/publicdisplaydocumentpdf\/?cote=env\/jm\/mono(2016)67&doclanguage=en"},{"key":"17_CR42","unstructured":"OECD (2018a) Case study on grouping and read-across for nanomaterials \u2500 genotoxicity of nano-TiO2 Series on Testing and Assessment No. 292 JT03435966. Available from: http:\/\/www.oecd.org\/officialdocuments\/publicdisplaydocumentpdf\/?cote=ENV\/JM\/MONO(2018)28&docLanguage=En"},{"key":"17_CR43","doi-asserted-by":"publisher","unstructured":"OECD (2018b) OECD series on adverse outcome pathways No. 1 Users\u2019 Handbook supplement to the Guidance Document for developing and assessing Adverse Outcome Pathways. https:\/\/doi.org\/10.1787\/5jlv1m9d1g32-en","DOI":"10.1787\/5jlv1m9d1g32-en"},{"key":"17_CR44","unstructured":"OECD (2020a) Joint meeting of the chemicals committee and the working party on chemicals, pesticides and biotechnology Advancing Adverse Outcome Pathway (AOP) Development for Nanomaterial Risk Assessment and Categorisation Part 1\u00a0: Final Project Report and Recommen. (93)"},{"key":"17_CR45","unstructured":"OECD (2020b) Joint meeting of the chemicals committee and the working party on chemicals, pesticides and biotechnology Advancing Adverse Outcome Pathway (AOP) Development for Nanomaterial Risk Assessment and Categorisation Part 2\u00a0: Case Study on Tissue Injury Serie. (94)"},{"key":"17_CR46","unstructured":"OECD (2020c) Joint meeting of the chemicals committee and the working party on chemicals, pesticides and biotechnology Advancing Adverse Outcome Pathway (AOP) Development for Nanomaterial Risk Assessment and Categorization Part3\u00a0: Workshop Report and Recommendation. (95)"},{"issue":"3","key":"17_CR47","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.yrtph.2015.02.011","volume":"71","author":"G Patlewicz","year":"2015","unstructured":"Patlewicz G, Simon TW, Rowlands JC, Budinsky RA et al (2015) Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes. Regul Toxicol Pharmacol 71(3):463\u2013477. https:\/\/doi.org\/10.1016\/j.yrtph.2015.02.011","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"17_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/toxsci\/kfv181","volume":"148","author":"EJ Perkins","year":"2015","unstructured":"Perkins EJ, Antczak P, Burgoon L, Falciani F et al (2015) Adverse outcome pathways for regulatory applications: examination of four case studies with different degrees of completeness and scientific confidence. Toxicol Sci 148(1):14\u201325. https:\/\/doi.org\/10.1093\/toxsci\/kfv181","journal-title":"Toxicol Sci"},{"issue":"9","key":"17_CR49","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1002\/etc.4505","volume":"38","author":"EJ Perkins","year":"2019","unstructured":"Perkins EJ, Ashauer R, Burgoon L, Conolly R et al (2019) Building and applying quantitative adverse outcome pathway models for chemical hazard and risk assessment. Environ Toxicol Chem 38(9):1850\u20131865. https:\/\/doi.org\/10.1002\/etc.4505","journal-title":"Environ Toxicol Chem"},{"key":"17_CR50","doi-asserted-by":"publisher","unstructured":"Romeo D, Salieri B, Hischier R, Nowack B et al (2020) An integrated pathway based on in vitro data for the human hazard assessment of nanomaterials. Environ Int 137. https:\/\/doi.org\/10.1016\/j.envint.2020.105505","DOI":"10.1016\/j.envint.2020.105505"},{"key":"17_CR51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/B978-0-12-814655-2.00009-8","volume-title":"Biomarkers in toxicology","author":"M Sachana","year":"2019","unstructured":"Sachana M (2019) Adverse outcome pathways and their role in revealing biomarkers. In: Biomarkers in toxicology. Elsevier, pp 163\u2013170. https:\/\/doi.org\/10.1016\/B978-0-12-814655-2.00009-8"},{"issue":"1","key":"17_CR52","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/em.22339","volume":"61","author":"JC Sasaki","year":"2020","unstructured":"Sasaki JC, Allemang A, Bryce SM, Custer L et al (2020) Application of the adverse outcome pathway framework to genotoxic modes of action. Environ Mol Mutagen 61(1):114\u2013134. https:\/\/doi.org\/10.1002\/em.22339","journal-title":"Environ Mol Mutagen"},{"issue":"4","key":"17_CR53","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3390\/nano10040708","volume":"10","author":"A Serra","year":"2020","unstructured":"Serra A, Fratello M, Cattelani L, Liampa I et al (2020) Transcriptomics in toxicogenomics, part III: data modelling for risk assessment. Nano 10(4):708. https:\/\/doi.org\/10.3390\/nano10040708","journal-title":"Nano"},{"issue":"5","key":"17_CR54","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s00204-020-02774-7","volume":"94","author":"N Spinu","year":"2020","unstructured":"Spinu N, Cronin MTD, Enoch SJ, Madden JC et al (2020) Quantitative adverse outcome pathway (qAOP) models for toxicity prediction. Arch Toxicol 94(5):1497\u20131510. https:\/\/doi.org\/10.1007\/s00204-020-02774-7","journal-title":"Arch Toxicol"},{"key":"17_CR55","doi-asserted-by":"publisher","unstructured":"Tavares AM, Louro H, Antunes S, Quarr\u00e9 S et al (2014) Genotoxicity evaluation of nanosized titanium dioxide, synthetic amorphous silica and multi-walled carbon nanotubes in human lymphocytes. Toxicol In Vitro 28(1). https:\/\/doi.org\/10.1016\/j.tiv.2013.06.009","DOI":"10.1016\/j.tiv.2013.06.009"},{"issue":"3","key":"17_CR56","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.yrtph.2014.09.009","volume":"70","author":"KE Tollefsen","year":"2014","unstructured":"Tollefsen KE, Scholz S, Cronin MT, Edwards SW et al (2014) Applying adverse outcome pathways (AOPs) to support integrated approaches to testing and assessment (IATA). Regul Toxicol Pharmacol 70(3):629\u2013640. https:\/\/doi.org\/10.1016\/j.yrtph.2014.09.009","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"17_CR57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12989-016-0123-y","volume":"13","author":"G Vietti","year":"2015","unstructured":"Vietti G, Lison D, van den Brule S (2015) Mechanisms of lung fibrosis induced by carbon nanotubes: towards an adverse outcome pathway (AOP). Part Fibre Toxicol 13(1):11. https:\/\/doi.org\/10.1186\/s12989-016-0123-y","journal-title":"Part Fibre Toxicol"},{"issue":"2","key":"17_CR58","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/toxsci\/kfu199","volume":"142","author":"DL Villeneuve","year":"2014","unstructured":"Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M et al (2014a) Adverse outcome pathway (AOP) development I: strategies and principles. Toxicol Sci 142(2):312\u2013320. https:\/\/doi.org\/10.1093\/toxsci\/kfu199","journal-title":"Toxicol Sci"},{"issue":"2","key":"17_CR59","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/toxsci\/kfu200","volume":"142","author":"DL Villeneuve","year":"2014","unstructured":"Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M et al (2014b) Adverse outcome pathway development II: best practices. Toxicol Sci 142(2):321\u2013330. https:\/\/doi.org\/10.1093\/toxsci\/kfu200","journal-title":"Toxicol Sci"},{"key":"17_CR60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cotox.2019.02.006","volume":"18","author":"M Vinken","year":"2019","unstructured":"Vinken M (2019) Omics-based input and output in the development and use of adverse outcome pathways. Curr Opin Toxicol 18:8\u201312. https:\/\/doi.org\/10.1016\/j.cotox.2019.02.006","journal-title":"Curr Opin Toxicol"},{"issue":"11","key":"17_CR61","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1007\/s00204-017-2020-z","volume":"91","author":"M Vinken","year":"2017","unstructured":"Vinken M, Knapen D, Vergauwen L, Hengstler JG et al (2017) Adverse outcome pathways: a concise introduction for toxicologists. Arch Toxicol 91(11):3697\u20133707. https:\/\/doi.org\/10.1007\/s00204-017-2020-z","journal-title":"Arch Toxicol"},{"key":"17_CR62","doi-asserted-by":"publisher","unstructured":"Vinken M, Knapen D, Vergauwen L, Hengstler JG (2018) Europe PMC funders group adverse outcome pathways: a concise introduction for toxicologists. 91(11):3697\u20133707. https:\/\/doi.org\/10.1007\/s00204-017-2020-z.Adverse","DOI":"10.1007\/s00204-017-2020-z.Adverse"},{"issue":"33","key":"17_CR63","doi-asserted-by":"publisher","first-page":"1700776","DOI":"10.1002\/smll.201700776","volume":"13","author":"X Wang","year":"2017","unstructured":"Wang X, Liao Y-P, Telesca D, Chang CH et al (2017) The genetic heterogeneity among different mouse strains impacts the lung injury potential of multiwalled carbon nanotubes. Small 13(33):1700776. https:\/\/doi.org\/10.1002\/smll.201700776","journal-title":"Small"},{"key":"17_CR64","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/978-3-319-66084-4_17","volume-title":"A systems biology approach to advancing adverse outcome pathways for risk assessment","author":"C Willett","year":"2018","unstructured":"Willett C, Fitzpatrick S, Meek B, Westmoreland C (2018) Use of adverse outcome pathways in human risk assessment and toxicology. In: A systems biology approach to advancing adverse outcome pathways for risk assessment. Cham, Springer International Publishing, pp 349\u2013378. https:\/\/doi.org\/10.1007\/978-3-319-66084-4_17"},{"issue":"2","key":"17_CR65","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1093\/toxsci\/kfw207","volume":"155","author":"C Wittwehr","year":"2017","unstructured":"Wittwehr C, Aladjov H, Ankley G, Byrne HJ et al (2017) How adverse outcome pathways can aid the development and use of computational prediction models for regulatory toxicology. Toxicol Sci 155(2):326\u2013336. https:\/\/doi.org\/10.1093\/toxsci\/kfw207","journal-title":"Toxicol Sci"}],"container-title":["Advances in Experimental Medicine and Biology","Nanotoxicology in Safety Assessment of Nanomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-88071-2_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T07:11:52Z","timestamp":1658128312000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-88071-2_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783030880705","9783030880712"],"references-count":65,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-88071-2_17","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"19 May 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}